ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 151 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2020. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4 | -20.0% | 8,211 | 0.0% | 0.00% | – |
| Q1 2023 | $5 | 0.0% | 8,211 | 0.0% | 0.00% | – |
| Q4 2022 | $5 | -100.0% | 8,211 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $14,000 | +40.0% | 8,211 | -2.1% | 0.00% | 0.0% |
| Q2 2022 | $10,000 | +100.0% | 8,383 | +1.9% | 0.00% | – |
| Q1 2022 | $5,000 | -80.0% | 8,227 | -63.9% | 0.00% | -100.0% |
| Q4 2021 | $25,000 | -44.4% | 22,813 | -7.0% | 0.00% | -50.0% |
| Q3 2021 | $45,000 | -32.8% | 24,522 | -3.3% | 0.00% | -33.3% |
| Q2 2021 | $67,000 | -26.4% | 25,351 | 0.0% | 0.00% | -40.0% |
| Q1 2021 | $91,000 | +40.0% | 25,351 | -2.0% | 0.01% | +25.0% |
| Q4 2020 | $65,000 | -3.0% | 25,858 | -2.3% | 0.00% | 0.0% |
| Q3 2020 | $67,000 | -23.0% | 26,473 | +0.3% | 0.00% | -33.3% |
| Q2 2020 | $87,000 | +29.9% | 26,386 | -3.1% | 0.01% | 0.0% |
| Q1 2020 | $67,000 | -48.9% | 27,233 | -2.0% | 0.01% | -33.3% |
| Q4 2019 | $131,000 | – | 27,796 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 15,461,829 | $2,037,869 | 0.36% |
| MSD Partners, L.P. | 15,151,516 | $1,996,970 | 0.16% |
| MSD Partners, L.P. | 7,575,758 | $998,485 | 0.08% |
| MAGNOLIA CAPITAL ADVISORS LLC | 865,938 | $65,552 | 0.03% |
| Allred Capital Management, LLC | 253,000 | $33,345 | 0.02% |
| CHIRON CAPITAL MANAGEMENT, LLC | 77,023 | $10,152 | 0.01% |
| Boxer Capital, LLC | 1,100,000 | $144,980 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 569,566 | $75 | 0.01% |
| Sugarloaf Wealth Management, LLC | 75,500 | $9,951 | 0.00% |
| Owen LaRue, LLC | 11,825 | $1,559 | 0.00% |